Compare Cassava Sciences Inc (FLNA) vs Herbalife Nutrition Ltd (HLF) Price & Performance

FLNA trades at $1.06, down 2.75% today, with a bearish technical signal from moving averages but neutral oscillators. The stock shows a low P/B of 0.78, yet profitability metrics are negative, including a -79.59% ROE and -$90.97M net income for 2025. Recent Q1 2026 earnings beat expectations, and analyst consensus is 66.7% buy. News highlights Q1 financial results and a scientific presentation on TSC-related epilepsy therapies.

Outlook remains speculative due to persistent losses and negative cash flows, offset by strong analyst support and recent earnings beats. Key risks include funding needs for drug development and competitive pressures, while potential upside hinges on clinical progress in TSC-related epilepsy treatments.

HLF trades at $12.45, up 1.72% today, with a bearish technical signal from moving averages. The company shows stable revenue around $5B annually, with a net income margin of 4.66% in 2025. Recent Q1 2026 earnings beat expectations, and the company raised full-year guidance. Positive news includes inclusion in TIME's America's Best Companies 2026 and a major debt refinancing, though insider selling and negative shareholder equity present concerns.

The outlook is mixed: strong brand recognition and earnings beats support upside, but high debt levels and bearish technicals pose risks. Analyst consensus is bullish with 57.7% buy ratings, yet the stock faces headwinds from competitive pressures and reliance on international growth markets like India.